Nephrogenic fibrosing dermopathy treated with extracorporeal photopheresis: Role of gadolinium?;Dermopathie néphrogénique fibrosante traitée par photochimiothérapie extracorporelle: Rôle du gadolinium?

Annales de Dermatologie et de Venereologie

Volumn 134, Issue 8-9, 2007, Pages 667-671

  Kintossou, R ^a   D'Incan, M ^a,c   Chauveau, D ^b   Bens, G ^a   Franck, F ^a   Dauplat, M M ^a   Viraben, R ^b   Dechelotte P ^a   Souteyrand, P ^a  

^a UNIVERSITÉ CLERMONT AUVERGNE   (France)

^b UNIVERSITÉ DE TOULOUSE   (France)

^c HÔTEL DIEU   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GADODIAMIDE; PREDNISONE;

AGED; ARTICLE; CASE REPORT; HUMAN; HUMAN TISSUE; MALE; NEPHROGENIC FIBROSING DERMOPATHY; PUVA; SKIN BIOPSY; TREATMENT OUTCOME;

EID: 34948851818     PISSN: 01519638     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0151-9638(07)91830-X     Document Type: Article

References (24)

1. Introcaso CE, Hivnor C, Cowper S, Werth VP. Nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis: a case series of nine patients and review of the literature. Int J Dermatol 2007;46:447-52.
2. Cowper S, Robin H, Steinberg S, Su L, Gupta S, Le Boit P. Scleromyxedema-like cutaneous diseases in renal-dialysis patients. Lancet 2000;356:1000-1.
3. Chiu H, Wells G, Carag H, Canova E, Firpi RJ. Nephrogenic fibrosing dermopathy: a rare entity in patients awaiting hepatic transplantation. Liver Transplant 2004;10:465-70.
4. Jain SM, Wesson S, Hassanein A, Canova E, Hoy M, Fennel RS, et al. Nephrogenic fibrosing dermopathy in pediatric patients. Pediatr Nephrol 2004,19:467-70.
5. Sadowski EA, Bennet LK, Chan MR, Wentland AL, Garret AL, Garret RW, Djamani A. Nephrogenic systemic fibrosis: risk factors and incidence. Radiology 2007;243:148-57.
6. Streams BN, Liu V, Liegeois N, Moschella SM. Clinical and pathologic features of nephrogenic fibrosing dermopathy: a report of two cases. J Am Acad Dermatol 2003;48:42-7.
7. Ting WW, Stone MS, Madison KC, Kurtz K. Nephrogenic fibrosing dermopathy with systemic involvement. Arch Dermatol 2003;139:903-9.
8. Levine JM, Taylor RA, Elman LB, Bird SJ, Lavi E, Stolzenberg ED, et al. Involvement of skelettal muscle in dialysis-associated fibrosis (nephrogenic fibrosing dermopathy). Muscle Nerve 2004,30:569-7.
9. Ortonne N, Lipsker D, Chantrel F, Boehm N, Grosshans E, Cribier B. Presence of CD45RO + CD34 + cells with collagen synthesis activity in nephrogenic fibrosing dermopathy: a new pathogenic hypothesis. Br J Dermatol 2004;150:1050-2.
10. Glaish AS, Martinelli PT, Markus RF, Hsu S. Generalised elastolysis followed nephrogenic fibrosing dermopathy. J Am Acad Dermatol 2005,53:174-6.
11. Boyd AS, Zic JA, Braham JL. Gadolinium deposition in nephrogenic fibrosing dermopathy. J Am Acad Dermatol 2007;56:27-30.
12. Cowper SE, Su LD, Bhawan J, Robin HS, LeBoit PE. Nephrogenic fibrosing dermopathy. Am J Dermathopathol 2001;23:383-93.
13. Ruiz-Genao DP, Pascual-Lopez MP, Frage S, Aragüés M, Garcia-Diez A. Osseous metaplasia in the setting of nephrogenic fibrosing dermopathy. J Cutan Pathol 2005;32:172-5.
14. Grobner T. Gadolinium - a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis? Nephrol Dial Transplant 2006;21:1104-8.
15. Kuo PH, Kanal E, Abu-Alfa AK, Cowper SE. Gadolinium-based contrast agents and nephrogenic systemic fibrosis. Radiology 2007;242:647-9.
16. Thomsen HS, Morcos SK, Dawson P. Is there a causal relation between the administration of gadolinium based contrast media and the development of nephrogenic systemic fibrosis? Clin Radiol 2006;61:905-6.
17. Edward M, Fitzgerald L, Thind C, Leman J, Burden AD. Cutaneous mucinosis associated with dermatomyositis and nephrogenic fibrosing dermopathy: fibroblast hyaluronan synthesis and the effect of patient serum. Br J Dermatol 2007;156:473-9.
18. Swaminathan S, Ahmed I, McCarthy JT, Albright RC, Pittelkow MR, Caplice NM, et al. Nephropathic fibrosing dermopathy and high-doses erythropoietin therapy. Ann Intern Med 2006;145:234-5.
19. D'Incan M, Kanold J, Halle P, de Lumley L, Souteyrand P, Demeocq F. La photophérèse extracorporelle : une alternative au traitement de la réaction du greffon contre l'hôte résistante. Ann Dermatol Venereol 2000;127:166-70.
20. Gilliet M, Cozzio A, Burg G, Nestle FO. Successful treatment of three cases of nephrogenic fibrosing dermopathy with extracorporeal photopheresis. Br J Dermatol 2005;152:531-6.
21. Lauchli S, Zortea-Caflish C, Nestle FO, Burg G, Kempf W. Nephrogenic fibrosing dermopathy treated with extracorporeal photopheresis. Dermatology 2004;208:278-80.
22. Mackay-Wiggan JM, Cohen DJ, Hardy MA, Knobler EH, Grossman ME. Nephrogenic fibrosing dermopathy (scleromyxedema-like illness of renal disease). J Am Acad Dermatol 2003;48:55-60.
23. Wahba IM, White K, Meyer M, Simpson EL. The case for ultraviolet light therapy in nephrogenic fibrosing dermopathy - Report of two cases and review of the literature. Nephrol Dial Transplant 2007;22:631-6.
24. Cowper SE. Nephrogenic fibrosing dermopathy: the first 6 years. Curr Opin Rheumatol 2003;15:785-90.